Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Victor Hernandez

Orthopaedic Surgery Miami, FL Medical Doctor

NPI 1417282971 CMS profile 403270

1400 Nw 12Th Ave, Suite 2 - East Bulding, Miami, FL 33136

Open in the dashboard

General payments

$290,605

332 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Victor Hernandez of Miami, FL is reported in the CMS Open Payments database as having received $290,605 across 332 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $115,266 79
2024 General $68,535 74
2023 General $50,627 72
2022 General $2,584 20
2021 General $1,523 19
2020 General $11,859 21
2019 General $40,213 47

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Victor Hernandez
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Victor Hernandez were reported at $115,266. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Victor Hernandez Orthopaedic Surgery median Middle half National median
2019 $40,213 $644 $140–$2,844 $163
2020 $11,859 $312 $75–$1,860 $114
2021 $1,523 $520 $117–$2,495 $132
2022 $2,584 $598 $128–$2,731 $149
2023 $50,627 $461 $128–$2,264 $160
2024 $68,535 $497 $134–$2,475 $164
2025 $115,266 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $121,330 110 payments
  2. Medical Device Business Services, Inc. $56,998 19 payments
  3. Stryker Corporation $34,444 98 payments
  4. Lilly USA, LLC $17,781 23 payments
  5. Uoc USA Inc $16,613 9 payments
  6. DePuy Synthes Products, Inc. $16,201 30 payments
  7. Ethicon Endo-Surgery Inc. $10,200 1 payment
  8. Encore Medical, LP $7,854 12 payments
  9. Pfizer Inc. $4,102 1 payment
  10. Ethicon Inc. $1,755 1 payment
  11. Other $3,328 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $174,616 52 payments
  2. Education $83,760 24 payments
  3. Food and Beverage $15,696 211 payments
  4. Travel and Lodging $10,533 44 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,000 1 payment
Products named General payments · program years 2019–2025
  1. Arcos $61,738 20 payments
  2. G7 $56,051 20 payments
  3. Avenir $49,749 24 payments
  4. ACTIS $42,757 11 payments
  5. Velys $42,617 10 payments
  6. 1588 HD 3 CHIP CAMERA $26,400 2 payments
  7. Persona $24,270 16 payments
  8. Taperloc $18,920 8 payments
  9. U2, PSA, USTARII, U-MotionII, Conformity $15,730 1 payment
  10. STRATAFIX $10,294 2 payments
  11. Other $46,478 215 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

121

Median for Orthopedic Surgery: 203

Drug cost

$885

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 12 $438
Tramadol Hcl Generic 29 $134
Cyclobenzaprine Hcl Generic 21 $102
Methylprednisolone Generic 11 $82
Alendronate Sodium Generic 14 $76
Meloxicam Generic 34 $54

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$207,646

Of which drugs: $18,569

Medicare patients

340

Average age 73

Services billed

1,023

227 women, 113 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 34%
Diabetes 31%
Osteoporosis 26%
Depression 25%
Chronic kidney disease 21%
COPD 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose J7327 Office 21 33 $17,937
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 30 151 $118

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

332 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record